Literature DB >> 8871646

Postinduction transcriptional repression of E-selectin and vascular cell adhesion molecule-1.

M A Read1, A S Neish, M E Gerritsen, T Collins.   

Abstract

TNF-alpha induction of the E-selectin and vascular cell adhesion molecule-1 (VCAM-1) genes leads to transient accumulation of high levels of mRNA in endothelial cells. The increase in these mRNAs after induction is due to an increase in the rate of gene transcription, which is maintained for several hours in the continuous presence of cytokine. Cytokine-induced transcriptional activation of these genes requires the transcription factor, nuclear factor-kappaB. Following removal of TNF-alpha, there is rapid postinduction transcriptional repression common to both of these genes. The repression is protein synthesis dependent and correlates with protein synthesis-dependent loss of both the p50 and p65 subunits of nuclear factor-kappaB from the nucleus. IkappaBalpha is capable of specifically displacing endothelial-derived heterodimeric p50/p65 from the E-selectin and VCAM-1 kappaB elements, while having no effect on binding of p50 homodimer. In the presence of agents that block proteasomal degradation of IkappaBalpha, endogenous IkappaBalpha can be visualized in the nucleus of both resting and TNF-alpha-activated endothelial cells. Endogenous IkappaBalpha is readily detected in the nucleus of HeLa cells, and its nuclear localization is increased following removal of TNF-alpha. Repression of E-selectin and VCAM-1 transcription following cytokine removal requires the loss of nuclear p50 and p65, and involves IkappaBalpha. This postinduction transcription repression mechanism may be one component of a program that prevents inappropriate and prolonged expression of adhesion molecules.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8871646

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Distinct domains of IkappaBalpha regulate c-Rel in the cytoplasm and in the nucleus.

Authors:  I Luque; C Gélinas
Journal:  Mol Cell Biol       Date:  1998-03       Impact factor: 4.272

2.  Distinct functional properties of IkappaB alpha and IkappaB beta.

Authors:  K Tran; M Merika; D Thanos
Journal:  Mol Cell Biol       Date:  1997-09       Impact factor: 4.272

3.  Synovial fibroblasts and the sphingomyelinase pathway: sphingomyelin turnover and ceramide generation are not signaling mechanisms for the actions of tumor necrosis factor-alpha.

Authors:  M E Gerritsen; C P Shen; C A Perry
Journal:  Am J Pathol       Date:  1998-02       Impact factor: 4.307

4.  Regulation of IkappaBbeta expression in testis.

Authors:  Lucy M Budde; Chun Wu; Christopher Tilman; Iris Douglas; Sankar Ghosh
Journal:  Mol Biol Cell       Date:  2002-12       Impact factor: 4.138

5.  4-trifluoromethyl derivatives of salicylate, triflusal and its main metabolite 2-hydroxy-4-trifluoromethylbenzoic acid, are potent inhibitors of nuclear factor kappaB activation.

Authors:  Y Bayón; A Alonso; M Sánchez Crespo
Journal:  Br J Pharmacol       Date:  1999-03       Impact factor: 8.739

6.  Sustained elevated levels of VCAM-1 in cultured fibroblast-like synoviocytes can be achieved by TNF-alpha in combination with either IL-4 or IL-13 through increased mRNA stability.

Authors:  D Croft; P McIntyre; A Wibulswas; I Kramer
Journal:  Am J Pathol       Date:  1999-04       Impact factor: 4.307

7.  RelB modulation of IkappaBalpha stability as a mechanism of transcription suppression of interleukin-1alpha (IL-1alpha), IL-1beta, and tumor necrosis factor alpha in fibroblasts.

Authors:  Y Xia; S Chen; Y Wang; N Mackman; G Ku; D Lo; L Feng
Journal:  Mol Cell Biol       Date:  1999-11       Impact factor: 4.272

8.  Chromatin modification and the endothelial-specific activation of the E-selectin gene.

Authors:  Leonard C Edelstein; Amy Pan; Tucker Collins
Journal:  J Biol Chem       Date:  2005-01-25       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.